The Antigen Home Diagnostic Testing Market Size is predicted to witness a 8.51% CAGR during the forecast period for 2024-2031. Antigen home diagnostic testing involves using rapid tests at home to detect specific viral antigens, such as for COVID-19. These tests provide quick results, typically within minutes, using kits that include everything needed for sample collection and analysis. They are convenient for screening asymptomatic individual...
Report ID: 2617 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 177
The NeuN Antibody Market Size is valued at USD 39.7 Mn in 2023 and is predicted to reach USD 167.8 Mn by the year 2031 at a 20.4% CAGR during the forecast period for 2024-2031. The NeuN antibody is an essential instrument in neuroscience research for the precise identification of fully developed neurons in the central nervous system (CNS). NeuN, also known as Neuronal Nuclei, is a protein that is produced by the RBFOX3 gene. It is mostly found...
Report ID: 2607 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 170
The Parkinson’s Disease Therapeutic Market Size is valued at USD 4.22 billion in 2023 and is predicted to reach USD 6.51 billion by the year 2031 at a 5.7% CAGR during the forecast period for 2024-2031. Parkinson's disease is attributed to the loss of neurons in the part of the brain responsible for motor control. The exact etiology of nerve cell degeneration remains unknown; however, it is hypothesized that exposure to environmental ris...
Report ID: 2587 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 170
The OBP2A Antibody Market Size was valued at USD 102.9 Mn in 2023 and is predicted to reach USD 419.0 Mn by 2031 at a 19.5% CAGR during the forecast period for 2024-2031. An OBP2A antibody is a special kind of antibody that can identify and bind to the OBP2A protein. The OBP2A antibody market is poised for growth due to the favorable conditions created by the global expansion of the biomedical and pharmaceutical industries. Furthermore, as tar...
Report ID: 2590 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 180
The Zearalenone Antibody Market Size was valued at USD 11.8 Mn in 2023 and is predicted to reach USD 45.4 Mn by 2031 at an 18.7% CAGR during the forecast period for 2024-2031. Zearalenone antibodies can detect and bind to the mycotoxin zearalenone that fusarium produces. Several different Assays and diagnostic tests use the antibody to identify and quantify zearalenone in food and feed samples. This helps to ensure that agricultural and food s...
Report ID: 2591 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 170
The Gene Switch / Molecular Switch Market Size is valued at USD 0.69 Bn in 2023 and is predicted to reach USD 1.44 Bn by the year 2031 at an 9.9% CAGR during the forecast period for 2024-2031. Gene switches are locations on genes that are capable of binding regulatory molecules to start the transcription and translation processes that result in the expression of that particular gene. Gene switching pertains to the reversible on/off regulation ...
Report ID: 2595 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 168
The Recombinant Human Endostatin Market Size is valued at USD 133.3 Mn in 2023 and is predicted to reach USD 249.4 Mn by the year 2031 at a 8.3% CAGR during the forecast period for 2024-2031. Recombinant human endostatin is a naturally occurring protein in the human body that prevents angiogenesis and has been bioengineered. Genetic engineering methods are used to generate the recombinant form for medical uses. The increasing number of cancer ...
Report ID: 2597 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 170
The Periodontal Therapeutics Market Size was valued at USD 843.6 Mn in 2023 and is predicted to reach USD 1,497.4 Mn by 2031 at a 7.6% CAGR during the forecast period for 2024-2031. Periodontal disease encompasses a wide range of inflammatory conditions affecting the tissues surrounding the teeth. It primarily includes gingivitis (mild inflammation of the gums) and periodontitis (severe inflammation that can lead to tooth loss). Gingivitis is ...
Report ID: 2576 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 175
Radionuclide Drug Conjugates (RDC) Market Size is predicted to witness a 13.9% of CAGR during the forecast period for 2024-2031. Radionuclide Drug Conjugates (RDCs) represent a promising innovation in cancer treatment, utilizing a targeted approach to deliver radiation directly to tumor cells. By combining a radionuclide, targeting molecule, chelator, and linker, RDCs minimize harm to healthy tissues while effectively attacking cancer. This ta...
Report ID: 2567 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 180
Disseminated Intravascular Coagulation (DIC) Market Size is valued at USD 437.3 Mn in 2023 and is predicted to reach USD 563.8 Mn by the year 2031 at a 3.3% CAGR during the forecast period for 2024-2031. The Disseminated Intravascular Coagulation (DIC) market focuses on managing a serious condition characterized by abnormal blood clotting, involving key segments such as diagnostics (e.g., D-dimer tests), therapeutics (anticoagulants and blood ...
Report ID: 2573 |
Delivery: Immediate |
Published: July 2024 |
No. of Pages: 180
Pharmaceuticals